Proliferative Diabetic Retinopathy (PDR) Unknown Status Phase 4 Trials for Pegaptanib (DB04895)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

IndicationStatusPhase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01486771
Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)Treatment